Clinical Trials Logo

Filter by:
NCT ID: NCT04927351 Suspended - Surgery Clinical Trials

Nudges for Opioid Reduction After Major Surgery Trial

NORMS
Start date: November 17, 2021
Phase: N/A
Study type: Interventional

This is a prospective pilot trial to evaluate a new electronic medical record based intervention to improve discharges after surgery. The investigators hypothesize that standard discharge medications after surgery will help to optimize opioid prescribing and potentially decrease healthcare utilization in the first 30 days after surgery.

NCT ID: NCT04916002 Suspended - Clinical trials for Non-Small Cell Lung Cancer

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Start date: November 30, 2021
Phase: Phase 2
Study type: Interventional

The goal of this study is to learn if giving cemiplimab and vidutolimod together could be effective in treating advanced cancer. The main questions it aims to answer are: - How many participants' cancers respond to vidutolimod together with cemiplimab? - Is vidutolimod together with cemiplimab safe and well-tolerated? - How well does vidutolimod together with cemiplimab treat participants' cancer? Participants will receive trial treatment for up to 2 years. 30 days after stopping treatment, participants will have a follow-up visit. After that visit, the trial staff will continue to follow up with participants about every 3 months, until the trial ends.

NCT ID: NCT04912115 Suspended - Clinical trials for Nervous System Diseases

Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

Start date: October 5, 2021
Phase: Phase 2
Study type: Interventional

A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo-Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa-Induced Dyskinesia in Subjects with Parkinson's Disease.

NCT ID: NCT04910074 Suspended - Nerve Injury Clinical Trials

LLLT Effects on Inferior Alveolar Nerve (IAN) Recovery Post-orthognathic Surgery

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Low-level laser therapy (LLLT) is a well-studied technique that has been shown to improve recovery time and reduce pain and swelling in patients undergoing surgery, including orthognathic surgery, and has no known negative effects. This study will use two groups with patients randomly assigned to either the study group, receiving LLLT, or one receiving a placebo treatment, after they have lower jaw surgery. Measurements will be taken at 24 hours, 1 week, 2 week, 3 week, 4 week, 5 week, and 6 week post-op exams to check pain, swelling and nerve function, and the two groups will be compared to see if the LLLT group has any difference

NCT ID: NCT04909502 Suspended - Clinical trials for Relapsing Forms of Multiple Sclerosis

Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis

Start date: October 19, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of EHP-101 in adult subjects with Relapsing Forms of Multiple Sclerosis (RMS).

NCT ID: NCT04906369 Suspended - Clinical trials for Anatomic Stage IV Breast Cancer AJCC v8

Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring

Start date: November 16, 2020
Phase:
Study type: Observational

This study evaluates if blood tests can detect changes in disease status during treatment for stage IV breast cancer. Information from this study may help researchers learn more about metastatic breast cancer and how to optimize treatment.

NCT ID: NCT04902053 Suspended - Clinical trials for Aortic Valve Replacement

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

INVIVITY
Start date: June 2028
Phase:
Study type: Observational

The primary objective of the INSPIRIS RESILIA Aortic Valve-in-valve (ViV) Surveillance Study ("the Study") is to capture Adverse Event information and valve measurement data from dysfunctional INSPIRIS RESILIA aortic valves before and after Valve-in-valve (ViV) treatment.

NCT ID: NCT04898985 Suspended - Covid-19 Clinical Trials

The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19

LLST-Cells
Start date: May 20, 2021
Phase:
Study type: Observational

Five hundred (500) patients participating in the LLS COVID-19 Registry, who have shown either no antibody or limited antibody response by way of the Spike Antibody test to one of the vaccinations authorized for emergency use (EUA) by FDA will participate in the LLS T-cells, Blood Cancer and COVID-19 Clinical Research Study. They will be followed for at least ten years (in the COVID-19 Registry). In addition, 500 patients with similar blood cancer diagnosis, also participating in the LLS COVID-19 Registry, who have shown full Spike antibody response to one of the vaccinations authorized for emergency use (EUA) by FDA will also be enrolled the LLS T-cells, Blood Cancer and COVID-19 Clinical Research Study for comparison (as a control arm) and will also be followed for at least 10 years (in the COVID-19 Registry).

NCT ID: NCT04898530 Suspended - Ulcerative Colitis Clinical Trials

Diet Patterns in IBD in Central Texas

Start date: June 8, 2021
Phase:
Study type: Observational

The purpose of the study is to understand the diet patterns, preferences, and impact of diet on daily living in our patients with IBD in Central Texas.

NCT ID: NCT04890158 Suspended - Clinical trials for Bronchopulmonary Dysplasia

Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.

Start date: December 7, 2021
Phase: N/A
Study type: Interventional

In this pilot study, the investigator team aims to evaluate whether standardized prone positioning compared to usual positioning improves moderate to severe bronchopulmonary dysplasia (BPD) rates as assessed at 36 weeks post conceptional age in very low birth weight preterm infants with bronchopulmonary dysplasia.